Hamlet BioPharma B

Hamlet BioPharma B

Pressreleases, rapporter och nyheter för Hamlet BioPharma B

Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet Pharma is proud to announce detailed timelines for the completion of the Phase I/II bladder cancer study
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet Pharma is proud to announce detailed timelines for the completion of the Phase I/II bladder cancer study
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet Pharma is proud to announce detailed timelines for the completion of the Phase I/II bladder cancer study
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Bolagspresentation i Stockholm 8 april 2019
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Bolagspresentation i Stockholm 8 april 2019
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Bolagspresentation i Stockholm 8 april 2019
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Styrelseledamoten Bengt Furberg avliden
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Tillverkning av peptiden Alpha1H för framtida kliniska studier
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Tillverkning av peptiden Alpha1H för framtida kliniska studier
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Reports: Delårsrapport 2 - Andra kvartalet (2018-10-01 - 2018-12-31)
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet Pharma has been granted permission for a 2-year follow up study
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet Pharma has been granted permission for a 2-year follow up study
Loading...